Patents by Inventor Lidia Demchyshyn

Lidia Demchyshyn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120295298
    Abstract: Disclosed herein is a method for measuring the contractility of intestinal tissue upon treatment with GLP-2 or a GLP-2 ligand. Also disclosed is an assay which directly measures the activity of GLP-2 or GLP-2 ligands ex vivo and permits the screening of putative GLP-2 ligands in native tissue.
    Type: Application
    Filed: August 2, 2012
    Publication date: November 22, 2012
    Applicant: NPS Pharmaceuticals, Inc.
    Inventors: Lidia Demchyshyn, Hong Wang
  • Publication number: 20120003681
    Abstract: Disclosed herein is a method for measuring the contractility of intestinal tissue upon treatment with GLP-2 or a GLP-2 ligand. Also disclosed is an assay which directly measures the activity of GLP-2 or GLP-2 ligands ex vivo and permits the screening of putative GLP-2 ligands in native tissue.
    Type: Application
    Filed: June 6, 2011
    Publication date: January 5, 2012
    Applicant: NPS Pharmaceuticals, Inc.
    Inventors: Lidia Demchyshyn, Hong Wang
  • Patent number: 7977061
    Abstract: Disclosed herein is a method for measuring the contractility of intestinal tissue upon treatment with GLP-2 or a GLP-2 ligand. Also disclosed is an assay which directly measures the activity of GLP-2 or GLP-2 ligands ex vivo and permits the screening of putative GLP-2 ligands in native tissue.
    Type: Grant
    Filed: January 22, 2009
    Date of Patent: July 12, 2011
    Assignee: NPS Pharmaceuticals Inc.
    Inventors: Lidia Demchyshyn, Hong Wang
  • Publication number: 20100003703
    Abstract: Disclosed herein is a method for measuring the contractility of intestinal tissue upon treatment with GLP-2 or a GLP-2 ligand. Also disclosed is an assay which directly measures the activity of GLP-2 or GLP-2 ligands ex vivo and permits the screening of putative GLP-2 ligands in native tissue.
    Type: Application
    Filed: January 22, 2009
    Publication date: January 7, 2010
    Applicant: NPS Pharmaceuticals, Inc.
    Inventors: Lidia Demchyshyn, Hong Wang
  • Patent number: 7498141
    Abstract: Disclosed herein is a method for measuring the contractility of intestinal tissue upon treatment with GLP-2 or a GLP-2 ligand. Also disclosed is an assay which directly measures the activity of GLP-2 or GLP-2 ligands ex vivo and permits the screening of putative GLP-2 ligands in native tissue.
    Type: Grant
    Filed: December 1, 2006
    Date of Patent: March 3, 2009
    Assignee: NPS Pharmaceuticals, Inc.
    Inventors: Lidia Demchyshyn, Hong Wang
  • Publication number: 20070184554
    Abstract: The invention disclosed herein demonstrates that that the adaptive process in the intestine can be tracked using plasma citrulline. It further demonstrates that plasma citrulline is of clinical utility as a biomarker for improvements in intestinal function.
    Type: Application
    Filed: December 1, 2006
    Publication date: August 9, 2007
    Applicant: NPS ALLELIX CORP.
    Inventors: Nathan Teuscher, Lidia Demchyshyn, David Wells
  • Publication number: 20070154959
    Abstract: Disclosed herein is a method for measuring the contractility of intestinal tissue upon treatment with GLP-2 or a GLP-2 ligand. Also disclosed is an assay which directly measures the activity of GLP-2 or GLP-2 ligands ex vivo and permits the screening of putative GLP-2 ligands in native tissue.
    Type: Application
    Filed: December 1, 2006
    Publication date: July 5, 2007
    Applicant: NPS ALLELIX CORP.
    Inventors: Lidia Demchyshyn, Hong Wang